Clinical Edge Journal Scan

PsA: Women have more severe disease than men


 

Key clinical point: Under tight settings for monitoring and treatment, women vs. men with psoriatic arthritis (PsA) had more severe disease and were less likely to achieve low disease activity (LDA), particularly if overweight.

Major finding: Women vs. men had worse mean PsA Disease Activity Score (3.5 vs. 2.7; P less than .001) and were more likely to not reach LDA (odds ratio [OR], 1.62; P = .002). Being overweight was associated with not reaching LDA (OR, 2.41-3.43; P less than .05) in women but not in men.

Study details: Findings are from secondary analysis of routine practice data of 855 outpatients with PsA who were critically monitored and treated.

Disclosures: The study was supported by the regional junior researcher grant from the Sint Maartenskliniek, Nijmegen, and the Radboudumc, Nijmegen, the Netherlands. The authors declared no competing interests.

Source: Mulder MLM et al. Rheumatology (Oxford). 2021 Apr 8. doi: 10.1093/rheumatology/keab338.

Recommended Reading

Researchers stress importance of second COVID-19 vaccine dose for infliximab users
MDedge Rheumatology
Rheumatology clinics find success with smoking cessation referral program
MDedge Rheumatology
Most patients with chronic inflammatory diseases have sufficient response to COVID-19 vaccination
MDedge Rheumatology
Boosting the presence of darker skin in rheumatology education
MDedge Rheumatology
Debate: Should biologics be used for milder cases of psoriasis?
MDedge Rheumatology
Psoriasis associated with an increased risk of COVID-19 in real-world study
MDedge Rheumatology
Safety and efficacy of upadacitinib in patients refractory to nonbiologic DMARDs
MDedge Rheumatology
OPAL Balance trial confirms long-term safety and efficacy of tofacitinib
MDedge Rheumatology
Guselkumab yields higher enthesitis resolution rates
MDedge Rheumatology
Comparative efficacy of guselkumab, IL-17A, and TNF inhibitors
MDedge Rheumatology